Promise and Pitfalls of Replacing Traditional Clinical Trials for Regulatory Decision Making

被引：0
|
作者：
Ross, Joseph S. [1 ]
机构：
[1] Yale Sch Med, New Haven, CT 06510 USA
来源：
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES | 2020年 / 23卷
基金：
美国国家卫生研究院; 美国医疗保健研究与质量局;
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：22S / 24S
页数：3
相关论文
共 50 条
  • [1] The promise and pitfalls of clinical trials overseas
    Normile, Dennis
    SCIENCE, 2008, 322 (5899) : 214 - 216
  • [2] Surrogate endpoint trials: Benefit and pitfalls for clinical decision making
    Bucher, H. C.
    INTERNIST, 2008, 49 (06): : 681 - 687
  • [3] Neuro-oncology clinical trials: Promise and pitfalls
    Gilbert, MR
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 149 - 150
  • [4] Promise and pitfalls of quantitative imaging in oncology clinical trials
    Kurland, Brenda F.
    Gerstner, Elizabeth R.
    Mountz, James M.
    Schwartz, Lawrence H.
    Ryan, Christopher W.
    Graham, Michael M.
    Buatti, John M.
    Fennessy, Fiona M.
    Eikman, Edward A.
    Kumar, Virendra
    Forster, Kenneth M.
    Wahl, Richard L.
    Lieberman, Frank S.
    MAGNETIC RESONANCE IMAGING, 2012, 30 (09) : 1301 - 1312
  • [5] The Gap Between Clinical Trials and Clinical Practice: The Use of Pragmatic Clinical Trials to Inform Regulatory Decision Making
    Brass, E. P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (03) : 351 - 355
  • [6] Benefit and pitfalls in the use of data from surrogate endpoint trials for clinical decision making
    Bucher, Heiner C.
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2010, 104 (03): : 230 - 237
  • [7] Brain tumor clinical trials: pitfalls and promise for the future.
    Gilbert M.R.
    Current Oncology Reports, 2000, 2 (6) : 473 - 475
  • [8] The Promise and Pitfalls of Pragmatic Clinical Trials for Improving Health Care Quality
    Haff, Nancy
    Choudhry, Niteesh K.
    JAMA NETWORK OPEN, 2018, 1 (06)
  • [9] Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?
    Kirsch-Stefan, Nadine
    Guillen, Elena
    Ekman, Niklas
    Barry, Sean
    Knippel, Verena
    Killalea, Sheila
    Weise, Martina
    Wolff-Holz, Elena
    BIODRUGS, 2023, 37 (06) : 855 - 871
  • [10] Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?
    Nadine Kirsch-Stefan
    Elena Guillen
    Niklas Ekman
    Sean Barry
    Verena Knippel
    Sheila Killalea
    Martina Weise
    Elena Wolff-Holz
    BioDrugs, 2023, 37 : 855 - 871
12345